Koyfin Home > Directory > Health Care > Ampio Pharmaceuticals > Cash Flow from Operations

Ampio Pharmaceuticals Cash Flow from Operations Chart (AMPE)

Ampio Pharmaceuticals annual/quarterly Cash Flow from Operations from 2009 to 2018. Cash flow from operating activities (CFO) is an accounting item that indicates the amount of money a company brings in from ongoing, regular business activities, such as manufacturing and selling goods or providing a service. Cash flow from operating activities does not include long-term capital or investment costs.
  • Ampio Pharmaceuticals Cash Flow from Operations for the quarter ending September 09, 2018 was $-3m a 19.89% decrease of -1m year over year
  • Ampio Pharmaceuticals Cash Flow from Operations for the last 12 months ending September 09, 2018 was $-12m a 7.88% decrease of -1m year over year
  • Ampio Pharmaceuticals Annual Cash Flow from Operations for 2017 was $-11m a -28.20% increase of 3m from 2016
  • Ampio Pharmaceuticals Annual Cash Flow from Operations for 2016 was $-15m a -80.81% increase of 12m from 2015
  • Ampio Pharmaceuticals Annual Cash Flow from Operations for 2015 was $-26m a -16.25% increase of 4m from 2014
Other Cash Flow Metrics:
  • Ampio Pharmaceuticals Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-3m a 68.32% decrease of -2m year over year
  • Ampio Pharmaceuticals Total Revenue for the quarter ending December 12, 2015 was $0m a 95.43% increase of 0m year over year
View Chart On Koyfin

Quarterly AMPE Cash Flow from Operations Data

09/2018$-3m
06/2018$-3m
03/2018$-4m
12/2017$-3m
09/2017$-3m
06/2017$-3m
03/2017$-3m
12/2016$-3m
09/2016$-2m
06/2016$-5m

Annual AMPE Cash Flow from Operations Data

2017$-11m
2016$-15m
2015$-26m
2014$-31m
2013$-19m
2012$-10m
2011$-9m
2010$-3m
2009$-1m